Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 277.28 g/mol |
---|---|
Molecular Formula | C12H15N5O3 |
XLogP3 | -0.8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 277.11748936 g/mol |
Monoisotopic Mass | 277.11748936 g/mol |
Topological Polar Surface Area | 126 A^2 |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 480 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Baraclude |
PubMed Health | Entecavir (By mouth) |
Drug Classes | Antiviral |
Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
Active Ingredient | Entecavir |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 0.5mg; 0.05mg/ml; 1mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 4 | |
---|---|
Drug Name | Entecavir |
PubMed Health | Entecavir (By mouth) |
Drug Classes | Antiviral |
Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
Active Ingredient | Entecavir |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.5mg; 1mg |
Market Status | Prescription |
Company | Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Baraclude |
PubMed Health | Entecavir (By mouth) |
Drug Classes | Antiviral |
Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
Active Ingredient | Entecavir |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 0.5mg; 0.05mg/ml; 1mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
4 of 4 | |
---|---|
Drug Name | Entecavir |
PubMed Health | Entecavir (By mouth) |
Drug Classes | Antiviral |
Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
Active Ingredient | Entecavir |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.5mg; 1mg |
Market Status | Prescription |
Company | Teva Pharms Usa |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Entecavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Entecavir, including repackagers and relabelers. The FDA regulates Entecavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Entecavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Entecavir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Entecavir supplier is an individual or a company that provides Entecavir active pharmaceutical ingredient (API) or Entecavir finished formulations upon request. The Entecavir suppliers may include Entecavir API manufacturers, exporters, distributors and traders.
click here to find a list of Entecavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Entecavir DMF (Drug Master File) is a document detailing the whole manufacturing process of Entecavir active pharmaceutical ingredient (API) in detail. Different forms of Entecavir DMFs exist exist since differing nations have different regulations, such as Entecavir USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Entecavir DMF submitted to regulatory agencies in the US is known as a USDMF. Entecavir USDMF includes data on Entecavir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Entecavir USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Entecavir suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Entecavir Drug Master File in Japan (Entecavir JDMF) empowers Entecavir API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Entecavir JDMF during the approval evaluation for pharmaceutical products. At the time of Entecavir JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Entecavir suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Entecavir Drug Master File in Korea (Entecavir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Entecavir. The MFDS reviews the Entecavir KDMF as part of the drug registration process and uses the information provided in the Entecavir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Entecavir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Entecavir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Entecavir suppliers with KDMF on PharmaCompass.
A Entecavir CEP of the European Pharmacopoeia monograph is often referred to as a Entecavir Certificate of Suitability (COS). The purpose of a Entecavir CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Entecavir EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Entecavir to their clients by showing that a Entecavir CEP has been issued for it. The manufacturer submits a Entecavir CEP (COS) as part of the market authorization procedure, and it takes on the role of a Entecavir CEP holder for the record. Additionally, the data presented in the Entecavir CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Entecavir DMF.
A Entecavir CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Entecavir CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Entecavir suppliers with CEP (COS) on PharmaCompass.
A Entecavir written confirmation (Entecavir WC) is an official document issued by a regulatory agency to a Entecavir manufacturer, verifying that the manufacturing facility of a Entecavir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Entecavir APIs or Entecavir finished pharmaceutical products to another nation, regulatory agencies frequently require a Entecavir WC (written confirmation) as part of the regulatory process.
click here to find a list of Entecavir suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Entecavir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Entecavir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Entecavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Entecavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Entecavir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Entecavir suppliers with NDC on PharmaCompass.
Entecavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Entecavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Entecavir GMP manufacturer or Entecavir GMP API supplier for your needs.
A Entecavir CoA (Certificate of Analysis) is a formal document that attests to Entecavir's compliance with Entecavir specifications and serves as a tool for batch-level quality control.
Entecavir CoA mostly includes findings from lab analyses of a specific batch. For each Entecavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Entecavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Entecavir EP), Entecavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Entecavir USP).
LOOKING FOR A SUPPLIER?